http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2811977-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcce63b212704284382017151a108fc4 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-32 |
filingDate | 2011-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da45b130da50c32dceec4f4fd1594e62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff9245b2e87628cb5204a2e0980f3897 |
publicationDate | 2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2811977-A1 |
titleOfInvention | Method of achieving a thymosin beta 4 concentration in a human patient |
abstract | The present invention provides embodiments which involve methods of providing a predetermined concentration of thymosin beta 4 (TB4) at a predetermined time, t, in a body portion of a live human patient. The methods can include determining a thymosin beta 4 treatment dosage (D) using Formula I: C = (A)D · t-B, wherein C is the predetermined concentration at time t, in ng/mL, D is the dosage of thymosin beta 4 administered in mg, t is the time elapsed after administration of dosage D in hours, A is about 30 to about 38, and B is about 0.5 to about 1; and administering the dosage (D) of thymosin beta 4 to the patient. Formula I may be, for example, C=(35.6)D · t-0.754 (Formula II). |
priorityDate | 2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.